Pharmaceutical companies have the difficult task of navigating complex regulatory environments

29.5.2024

Tell me if I'm wrong:

1 You think marketing tactics have inflated demand for specific drugs.

2 You are skeptical about the rigor of drug safety testing because of all the cases of drug recalls, manufacturing defects, and safety issues you have seen in the media.

3 You are convinced pharmaceutical companies' interactions with healthcare providers (like sponsored educational events, speaker programs, or financial incentives) influence medical decision-making.

4 You question the fairness of pricing decisions and the industry's commitment to affordability.

5 You read somewhere that if there is less concurrence on the drug markets, it's because long periods of patent exclusivity delay the availability of affordable generic alternatives.

6 You are saddened that some people cannot afford the medication they need due to increased prices.

So, how many have I gotten right?

😬 Probably all six.

Pharmaceutical companies have the difficult task of navigating complex regulatory environments while building trust with patients and stakeholders. They also need to ensure that the company's ethics, employees' behavior, and stakeholders' perceptions align. As many people are involved, ensuring everyone works ethically and complies with the rules is a hard task.

The good news is that there is something that pharmaceutical companies can do about that: providing all their employees with the knowledge and skills to make informed decisions in situations where regulations are complex and challenging to navigate and where ethical decisions are required. 🧠

That's our specialty. So, if you work in the pharmaceutical industry and need a proven way to educate your employees, contact us at serapy.ch. Our team of experts will create a customized, gamified online training program to support your activities.

Start improving compliance and reducing risks today.

Take action now and request a demo.